165 related articles for article (PubMed ID: 37650886)
41. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study.
Tien YC; Yen HH; Li CF; Liu MP; Hsue YT; Hung MH; Chiu YM
Arthritis Res Ther; 2018 Nov; 20(1):246. PubMed ID: 30382902
[TBL] [Abstract][Full Text] [Related]
42. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis B and C virus infection in Crohn's disease.
Biancone L; Pavia M; Del Vecchio Blanco G; D'Incà R; Castiglione F; De Nigris F; Doldo P; Cosco F; Vavassori P; Bresci GP; Arrigoni A; Cadau G; Monteleone I; Rispo A; Fries W; Mallardi B; Sturniolo GC; Pallone F;
Inflamm Bowel Dis; 2001 Nov; 7(4):287-94. PubMed ID: 11720317
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis B virus-associated B-cell non-Hodgkin lymphoma in non-endemic areas in Western Europe: Clinical characteristics and prognosis.
Lemaitre M; Brice P; Frigeni M; Hermine O; Arcaini L; Thieblemont C; Besson C
J Infect; 2020 Feb; 80(2):219-224. PubMed ID: 31846632
[TBL] [Abstract][Full Text] [Related]
45. The Prevalence of HBV Infection: A Retrospective Study of 13 Years in a Public Hospital of Northeast China.
Jin Y; Geng N; Zhao L; Li Y; Zheng L; Zhu W; Sheng Q; An Z; Wang J; Dou X; Bai H
Viral Immunol; 2020 Mar; 33(2):99-104. PubMed ID: 31834847
[TBL] [Abstract][Full Text] [Related]
46. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
Wang F; Xu RH; Han B; Shi YX; Luo HY; Jiang WQ; Lin TY; Huang HQ; Xia ZJ; Guan ZZ
Cancer; 2007 Apr; 109(7):1360-4. PubMed ID: 17326056
[TBL] [Abstract][Full Text] [Related]
47. Positive Rate of Different Hepatitis B Virus Serological Markers in Peking Union Medical College Hospital, a General Tertiary Hospital in Beijing.
Zhang Y; Bian S; Liu X; Xu S; Zhang L; Zhou B; Zhang W; Zhang Y; Xu Y; Deng G
Chin Med Sci J; 2016 Mar; 31(1):17-2. PubMed ID: 28031083
[TBL] [Abstract][Full Text] [Related]
48. The prognostic roles of hepatitis B virus antibody in diffuse large B-cell lymphoma patients.
Hu S; Chen N; Lu K; Zhen C; Sui X; Fang X; Li Y; Luo Y; Zhou X; Wang X
Leuk Lymphoma; 2021 Jun; 62(6):1335-1343. PubMed ID: 33399486
[TBL] [Abstract][Full Text] [Related]
49. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
[TBL] [Abstract][Full Text] [Related]
50. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
Chen YM; Chen HH; Huang WN; Chen YH; Hsieh TY; Yang SS; Lan JL; Chen DY
Int J Rheum Dis; 2019 Jun; 22(6):1145-1151. PubMed ID: 31117160
[TBL] [Abstract][Full Text] [Related]
51. Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.
Masarone M; De Renzo A; La Mura V; Sasso FC; Romano M; Signoriello G; Rosato V; Perna F; Pane F; Persico M
BMC Gastroenterol; 2014 Feb; 14():31. PubMed ID: 24533834
[TBL] [Abstract][Full Text] [Related]
52. Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.
Wang F; Xu RH; Luo HY; Zhang DS; Jiang WQ; Huang HQ; Sun XF; Xia ZJ; Guan ZZ
BMC Cancer; 2008 Apr; 8():115. PubMed ID: 18433487
[TBL] [Abstract][Full Text] [Related]
53. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
[TBL] [Abstract][Full Text] [Related]
54. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
55. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
[TBL] [Abstract][Full Text] [Related]
56. Inferior survival and frequent hepatic dysfunction in non-Hodgkin's lymphoma patients with HBV infection: a systematic review and meta-analysis.
Zhang MY; Gao F; Zhao YW; Ni BW; Huang HH; Hou J
Hematology; 2022 Dec; 27(1):70-79. PubMed ID: 34957924
[TBL] [Abstract][Full Text] [Related]
57. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
[TBL] [Abstract][Full Text] [Related]
58. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study.
Liu J; Zhang S; Wang Q; Shen H; Zhang M; Zhang Y; Yan D; Liu M
Lancet Infect Dis; 2016 Jan; 16(1):80-86. PubMed ID: 26268687
[TBL] [Abstract][Full Text] [Related]
59. [Comparative analysis of hepatitis B virus large protein, hepatitis B virus-DNA and Pre-S1 antigen in evaluating serum hepatitis B virus replication].
Xia F; Xu YH; Zheng MJ; Wang XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):501-505. PubMed ID: 28592093
[No Abstract] [Full Text] [Related]
60. The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.
Lu S; Xu Y; Mu Q; Cao L; Chen J; Zhu Z; Lou Y; Meng H; Qian W; Tong H; Mai W; Huang J; Yu W; Zhao X; Jin J
Leuk Lymphoma; 2015 Apr; 56(4):1027-32. PubMed ID: 25065698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
